Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes

NCT00568074 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: repaglinide
DRUG: Glurenorm®
DRUG: Glucobay®

Sponsor

Novo Nordisk A/S